These findings suggest that the impact of ANGPTL2 on progression of DCM may be less than that of other mechanisms, and that evaluating changes in cardiac ANGPTL2 production in DCM pathology might be useful to predict DCM progression, although further investigation is required. The gene discussed is ANGPTL2; the disease is familial dilated cardiomyopathy.